Clinical Oncology - Issue 2/2009
Reviews
45
Trastuzumab in the breast cancer treatment: efficacy and resistance mechanisms
P. Grell, M. Svoboda, M. Šimičková, P. Fabian, R. Vyzula
Original Articles
52
Epidemiological features of testicular cancer in the Slovak Republic – retrospective study
M. Ondrusova, D. Ondrus
58
Clinical relevance of chromosomal aberrations in bone and soft tissue tumors in children and young adults
E. Stejskalová, M. Jarošová, J. Mališ, D. Sumerauer, H. Urbánková, L. Krsková, K. Pýcha, J. Schovanec, J. Balcárková, V. Šmelhaus, D. Kodetová, J. Starý
67
The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells
D. Očadlíková, L. Zahradová, L. Kovářová, J. Smejkalová, L. Pour, P. Vidláková, D. Kyjovská, J. Moravcová, M. Rycová, H. Novotná, I. Jelínková, M. Penka, J. Michálek, R. Hájek
Case Reports
73
Bevacizumab in combination with capecitabine and irinotecan (XELIRi) in treatment of metastatic colorectal cancer
I. Kocáková, I. Kocák, M. Svoboda, R. Němeček, Z. Řehák, M. Standara
Clinical Oncology
2009 Issue 2
Most read in this issue
- The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells
- Trastuzumab in the breast cancer treatment: efficacy and resistance mechanisms
- Clinical relevance of chromosomal aberrations in bone and soft tissue tumors in children and young adults
- Bevacizumab in combination with capecitabine and irinotecan (XELIRi) in treatment of metastatic colorectal cancer